The Procter & Gamble Company
Bear Case (25th pct.)
-49.5% vs price
Base Case (Median)
-36.1% vs price
Bull Case (75th pct.)
-18.8% vs price
◇ = Current price | |Bear |Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $83.37 | -45.3% | High (40%) |
| PE Comparable | $125.17 | -17.9% | Medium (25%) |
| Growth Trajectory DCF | $70.55 | -53.7% | Medium (20%) |
| Graham Number | $57.11 | -62.5% | High (80%) |
| EV/EBITDA | $97.46 | -36.1% | Medium (20%) |
| EV/FCF | $122.46 | -19.7% | Medium (20%) |
| Earnings Power Value | $129.23 | -15.3% | High (70%) |
Based on 7 out of 8 methods, PG appears overvalued at the current price of $152.49. The base case fair value of $97.46 implies 36.1% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.